RightEye Neuro Vision Concussion Test Unveiled at American Academy of Optometry Show

NEW ORLEANS & WASHINGTON–(BUSINESS WIRE)–RightEye LLC, a health technology company using eye tracking to revolutionize vision performance and patient care, today announced at the 2015 American Academy of Optometry show in New Orleans the launch of RightEye Neuro Vision — a new 15-second concussion test that helps health care providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time. “It’s common for concussion patients to be in denial


Publication Exclusive: Now is the time to prepare for possible introduction of lifitegrast

Summer is over, even for empty nesters like yours truly. It is “back to school” for all of us in the office, too, as many of us enter our busy seasons. Along with the usual sense of excitement in the air that comes with cooler nights and the sights and sounds of activity on the gridiron, we are on the edge of an exciting new age in the treatment of dry eye. Or maybe not. Or only sort of. I am talking, of course, of the impending FDA decision due on the filing of Shire’s new drug application for lifitegrast, a new medicine for the treatment of dry eye.The only thing of which we can be certain is that you will soon become familiar with the heretofore forgotten term “dysgeusia.”